{
    "nctId": "NCT06120595",
    "briefTitle": "Intervention Study Based on Real-world Data to Improve Quality of Life After Breast Cancer Treatment, the REBECCA-2 Study",
    "officialTitle": "REBECCA-2 Study: Research on Breast Cancer Induced Chronic Conditions Supported by Causal Analysis of Multi-source Data",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Cancer Related Fatigue",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 81,
    "primaryOutcomeMeasure": "Quality of life (QoL) measured by the SF36-questionnaire.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants have had histologically proven M0 breast cancer (stage 0-II) breast cancer that require neoadjuvant or adjuvant chemo- and/or radio-therapy at least and no more than 3 months pre-study initiation.\n* Age between 19 and 80 years\n* Have increased life expectancy beyond the initial 3 months post-treatment.\n* Have the ability to understand protocol, participate in testing and willingness to sign a written informed consent.\n* Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.\n\nExclusion Criteria:\n\n* Male breast cancer patients\n* Patients that are not willing to sign an informed consent form\n* A previous cancer diagnosis (excluding skin cancers treated by surgery only)\n* Patients previously treated by any form of chemo/radiotherapy.",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}